Uday Baldota

Uday B. serves as a member of the Board of Directors at Collabrix Inc. since 2022 and has been the CEO at Taro Pharmaceutical Industries since 2016, where Uday also holds a board position. Prior experience includes serving as a board member for the Association for Accessible Medicines from 2020 to 2022, and significant roles at SUN PHARMA from 2005 to 2017, including Global Chief Financial Officer. Uday was part of the management team at Lafarge India from 1999 to 2005, and held multiple roles at Sun Pharmaceutical Industries Ltd between 1995 and 1999. Uday began a professional career as a Management Consultant at Andersen Consulting from 1992 to 1994. Uday holds a PGDM from the Indian Institute of Management Ahmedabad, participated in the Lafarge Programme in International Leadership at INSEAD, and earned a B. Tech. in Chemical Engineering from the Indian Institute of Technology, Delhi.